The American Journal of Accountable Care > December 2016
The American Journal of Accountable Care - December 2016
The American Journal of Accountable Care
December 14, 2016 – Edward Anselm, MD
Accountable care organizations are well positioned to leverage a significant impact on tobacco control. A review of the changing landscape of tobacco use can help optimize performance.
December 14, 2016
In a presentation at the 6th Annual Live Meeting of the ACO & Emerging Healthcare Delivery Coalition™, hosted by The American Journal of Managed Care® on October 20-21, 2016, Ayman Chit, PhD, presented results from multiple clinical trials demonstrating the efficacy of Fluzone High-Dose vaccine.
December 14, 2016 – Beth M. Beaudin-Seiler, PhD, and Kieran Fogarty, PhD
Hospitals receiving national quality awards showed better performance in selected outcomes variables compared with hospitals that had not received these awards.
December 15, 2016 – Esther Hsiang, BA; Andrew T. Rogers, BS; Daniel J. Durand, MD; Scott Adam Berkowitz, MD, MBA
The authors describe best practices for Web design in the accountable care organization space in order to enhance engagement with patients and providers.
December 15, 2016 – Christine J. Manta, BA; Richard Caplan, PhD; Jennifer Goldsack, MChem, MA, MBA; Shawn Smith, MBA; and Edmondo Robinson, MD, MBA
Health information technologies can be implemented without impact on patient satisfaction. The lacking synergistic relationship should be concerning to stakeholders for optimizing costs and quality.
December 16, 2016 – Anthony D. Slonim, MD, DrPH, and Amber M. Maraccini, PhD
Recent election results raise questions about the future of healthcare programs and the coordination of patient care in our nation.
December 16, 2016 – Sheri D. Pruitt, PhD, and Dannielle E. Richardson
This study demonstrates patient acceptance of a virtual health coach while waiting for the physician to enter the primary care exam room.
December 16, 2016 – Neil D. Minkoff, MD
Integrating behavioral and physical health services within an accountable care organization offers a significant opportunity to address both behavioral health conditions and substance use disorders, as well as to improve outcomes and reduce costs.
December 16, 2016 – Sean Bowman, MPH; Mazi Rasulnia, PhD, MBA, MPH; Dhiren Patel, PharmD, CDE, BC-ADM, BCACP; David Masom, BSc; Margaret Belshé, BA; and William Wright, MBA, MPH
A chronic disease management company presents promising preliminary results from their remote intensive behavioral counseling intervention, aimed at addressing type 2 diabetes.